Suppr超能文献

放射性变化与Gliadel 植入术在复发性高级别脑胶质瘤患者中的相关性的临床意义。

The clinical significance of radiological changes associated with gliadel implantation in patients with recurrent high grade glioma.

机构信息

Department of Neurosurgery, Tel-Aviv Medical Center, affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, 6 Weizman Street, 6423906, Tel-Aviv, Israel.

出版信息

Sci Rep. 2023 Jan 2;13(1):11. doi: 10.1038/s41598-022-27128-4.

Abstract

Gliadel occasionally induces edema following its implantation. We aimed to correlate such post-surgical radiological changes to its efficacy and subsequent survival. Fifty-six patients with recurrent high grade glioma were treated between 2005 and 2016 with Gliadel implantation. Volumetric measurements of MRI features, including FLAIR abnormalities, tumor bulk (volume of gadolinium enhancement on T1) and resection cavity volumes over time were conducted. To assess dynamics over time, linear regression trendlines for each of these were calculated and examined to correlate with survival. Median follow-up after resection was 21.5 months. Median survival post-Gliadel implantation and overall survival since diagnosis were 12 months and 22 months, respectively. A subgroup of patients (n = 6) with a transient increase in FLAIR changes volume over time survived significantly longer post-Gliadel compared to those who did not demonstrate such change (36 vs 12 months, p = .03). Positive trends, representing overall growth in volume over time, of tumor bulk and resection cavity predicted survival in multivariate analyses (hazard ratios 7.9 and 84, p = .003 and .002, respectively). Increase in tumor bulk and resection cavity over time were associated with decreased survival, while transient FLAIR increase was a favorable prognostic factor. This may represent a transient inflammatory process in the tumor, possibly stemming from a presumed immune-mediated anti-tumor response.

摘要

Gliadel 偶尔会在植入后引起水肿。我们旨在将这种术后影像学变化与其疗效和随后的生存联系起来。

2005 年至 2016 年间,56 名复发性高级别胶质瘤患者接受了 Gliadel 植入治疗。对 MRI 特征(包括 FLAIR 异常、肿瘤体积(钆增强 T1 上的体积)和切除腔体积)进行了随时间的体积测量。为了评估随时间的动态变化,对这些指标中的每一个都计算了线性回归趋势线,并对其与生存的相关性进行了检查。

切除后中位随访时间为 21.5 个月。Gliadel 植入后中位生存时间和诊断后总生存时间分别为 12 个月和 22 个月。亚组患者(n=6)随时间推移 FLAIR 变化体积增加与Gliadel 后存活时间明显更长相关(36 个月 vs 12 个月,p=0.03)。肿瘤体积和切除腔的总体体积随时间呈正增长趋势,在多变量分析中预测了生存(危险比分别为 7.9 和 84,p=0.003 和 0.002)。肿瘤体积和切除腔随时间的增加与生存时间缩短相关,而 FLAIR 短暂增加是有利的预后因素。这可能代表肿瘤中的短暂炎症过程,可能源自假定的免疫介导的抗肿瘤反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0339/9807577/2f2caf57b1d6/41598_2022_27128_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验